Sfoglia per Autore
microRNAs and human hepatocellular carcinoma
2013-01-01 Salvi, Alessandro; Abeni, Edoardo; CONDE MARTIN, Maria Isabel; Grossi, Ilaria; Arici, Bruna; Portolani, Nazario; Barlati, Sergio; DE PETRO, Giuseppina
Effects of miR-193a and sorafenib on hepatocellular carcinoma cells.
2013-01-01 Salvi, Alessandro; CONDE MARTIN, Maria Isabel; Abeni, Edoardo; Arici, Bruna; Grossi, Ilaria; Specchia, Claudia; Portolani, Nazario; Barlati, Sergio; DE PETRO, Giuseppina
LASP1 directly interacts with vimentin and its expression stratifies patients affected by human hepatocellular carcinoma
2013-01-01 Salvi, Alessandro; Scuri, S; Ferrari, Lia; Arici, Bruna; Abeni, Edoardo; Bongarzone, I; De Bortolo, M; Portolani, Nazario; Barlati, Sergio; DE PETRO, Giuseppina
MicroRNAs as Biomarkers of hepatocellular carcinoma and molecular targeted therapeutics with sorafenib
2014-01-01 Salvi, Alessandro; Abeni, Edoardo; Isabel, Conde; Grossi, Ilaria; Ferrari, Lia; Arici, Bruna; Barlati, Sergio; Portolani, Nazario; DE PETRO, Giuseppina
MicroRNA 193a negatively regulates urokinase and in combination with sorafenib impairs the aggressive properties of HCC cells
2014-01-01 Grossi, Ilaria; Salvi, Alessandro; I., Conde; Abeni, Edoardo; Arici, Bruna; Portolani, Nazario; Barlati, Sergio; DE PETRO, Giuseppina
The down-modulation of miR-23b in hepatocellular carcinoma is mediated by DNA methylation
2015-01-01 Grossi, I; Salvi, A; Arici, B; Portolani, N; De Petro, G.
Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma
2017-01-01 Grossi, I; Arici, B; Portolani, N; De Petro, G; Salvi, A.
Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells
2017-01-01 Abeni, Edoardo; Salvi, Alessandro; Marchina, Eleonora; Traversa, Michele; Arici, Bruna; DE PETRO, Giuseppina
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties.
In corso di stampa Salvi, Alessandro; CONDE MARTIN, Maria Isabel; Abeni, Edoardo; Arici, Bruna; Portolani, Nazario; Barlati, Sergio; DE PETRO, Giuseppina
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| microRNAs and human hepatocellular carcinoma | 1-gen-2013 | Salvi, Alessandro; Abeni, Edoardo; CONDE MARTIN, Maria Isabel; Grossi, Ilaria; Arici, Bruna; Portolani, Nazario; Barlati, Sergio; DE PETRO, Giuseppina | |
| Effects of miR-193a and sorafenib on hepatocellular carcinoma cells. | 1-gen-2013 | Salvi, Alessandro; CONDE MARTIN, Maria Isabel; Abeni, Edoardo; Arici, Bruna; Grossi, Ilaria; Specchia, Claudia; Portolani, Nazario; Barlati, Sergio; DE PETRO, Giuseppina | |
| LASP1 directly interacts with vimentin and its expression stratifies patients affected by human hepatocellular carcinoma | 1-gen-2013 | Salvi, Alessandro; Scuri, S; Ferrari, Lia; Arici, Bruna; Abeni, Edoardo; Bongarzone, I; De Bortolo, M; Portolani, Nazario; Barlati, Sergio; DE PETRO, Giuseppina | |
| MicroRNAs as Biomarkers of hepatocellular carcinoma and molecular targeted therapeutics with sorafenib | 1-gen-2014 | Salvi, Alessandro; Abeni, Edoardo; Isabel, Conde; Grossi, Ilaria; Ferrari, Lia; Arici, Bruna; Barlati, Sergio; Portolani, Nazario; DE PETRO, Giuseppina | |
| MicroRNA 193a negatively regulates urokinase and in combination with sorafenib impairs the aggressive properties of HCC cells | 1-gen-2014 | Grossi, Ilaria; Salvi, Alessandro; I., Conde; Abeni, Edoardo; Arici, Bruna; Portolani, Nazario; Barlati, Sergio; DE PETRO, Giuseppina | |
| The down-modulation of miR-23b in hepatocellular carcinoma is mediated by DNA methylation | 1-gen-2015 | Grossi, I; Salvi, A; Arici, B; Portolani, N; De Petro, G. | |
| Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma | 1-gen-2017 | Grossi, I; Arici, B; Portolani, N; De Petro, G; Salvi, A. | |
| Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells | 1-gen-2017 | Abeni, Edoardo; Salvi, Alessandro; Marchina, Eleonora; Traversa, Michele; Arici, Bruna; DE PETRO, Giuseppina | |
| miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. | In corso di stampa | Salvi, Alessandro; CONDE MARTIN, Maria Isabel; Abeni, Edoardo; Arici, Bruna; Portolani, Nazario; Barlati, Sergio; DE PETRO, Giuseppina |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile